This inventor holds 1 USPTO granted patent. Top assignee: Sutro Biopharma, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gang Yin: Innovator in Antibody Technology
Introduction
Gang Yin is a notable inventor recognized for his contributions to the field of biopharmaceuticals. He has made significant strides in developing innovative solutions that address critical medical challenges. His work primarily focuses on antibody technology, which plays a vital role in therapeutic applications.
Latest Patents
Gang Yin holds a patent titled "Anti-Tissue Factor Antibodies and Antibody Conjugates, Compositions Comprising Anti-Tissue Factor Antibodies or Antibody Conjugates, and Methods of Making and Using Anti-Tissue Factor Antibodies and Antibody Conjugates." This patent highlights his expertise in creating advanced antibody-based therapies that can potentially improve patient outcomes.
Career Highlights
Gang Yin is currently employed at Sutro Biopharma, Inc., where he continues to push the boundaries of biopharmaceutical research. His work at Sutro Biopharma focuses on developing innovative therapies that leverage the power of antibodies to treat various diseases. With 1 patent to his name, he has established himself as a key player in the industry.
Collaborations
Some of his notable coworkers include Amandeep Kaur Gakhal and Junhao Yang. Their collaborative efforts contribute to the advancement of research and development in the field of biopharmaceuticals.
Conclusion
Gang Yin's innovative work in antibody technology exemplifies the impact of dedicated inventors in the medical field. His contributions are paving the way for new therapeutic solutions that can enhance patient care and treatment efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile